Drugs affecting the gastrointestinal system

(&plusmn)17-HDHA is an autoxidation product of DHA in vitro. It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.

(&plusmn)17-HDHA is an autoxidation product of DHA in vitro. It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.

The racemic version of a CYP450 metabolite of arachidonic acid that potently inhibits proximal tubule ATPase activity.

The racemic version of a CYP450 metabolite of arachidonic acid that potently inhibits proximal tubule ATPase activity.

The racemic version of a CYP450 metabolite of arachidonic acid that potently inhibits proximal tubule ATPase activity.

(&plusmn)5-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The methyl ester of (&plusmn)5-HETE has no distinguishing biological activity.

(&plusmn)5-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The methyl ester of (&plusmn)5-HETE has no distinguishing biological activity.

(&plusmn)5-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The methyl ester of (&plusmn)5-HETE has no distinguishing biological activity.

(&plusmn)5-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The methyl ester of (&plusmn)5-HETE has no distinguishing biological activity.

(&plusmn)7-HDHA is an autoxidation product of DHA in vitro. It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.

(&plusmn)7-HDHA is an autoxidation product of DHA in vitro. It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.

(&plusmn)7-HDHA is an autoxidation product of DHA in vitro. It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.